1 / 22

ECPC Cancer Summit 2010, 13-14 October 2010

ECPC Cancer Summit 2010, 13-14 October 2010. The importance of cancer data & registries to understand the cancer burden (EUROCHIP). Dr. Andrea Micheli Director Descriptive Studies and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan.

lynsey
Download Presentation

ECPC Cancer Summit 2010, 13-14 October 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ECPC Cancer Summit 2010, 13-14 October 2010 The importance of cancer data & registries to understand the cancer burden (EUROCHIP) Dr. Andrea MicheliDirector Descriptive Studies and Health Planning UnitFondazione IRCCS “Istituto Nazionale dei Tumori”Milan

  2. LIFE EXPECTANCY IN EU-27, Ice, N, Ch2005-2009 Source: United Nations Population Division

  3. GDP per capita (PPP$) in EU-27, Ice, N, Ch2005-2009 Source: International Monetary Fund

  4. GDP and life expectancy at birth Life expectancy at birth $Purchasing Power Parityyrs (average) I) GDP< = 20,00073.3 II) 20,000 <GDP< = 30,00079.1 III) 30,000 <GDP< = 36,00079.6 IV) GDP>36,00080.0 I, Bulgaria, Romania, Latvia, Poland, Lithuania, Hungary, Estonia, Slovakia II, Portugal, Malta, Czech Republic, Slovenia, Cyprus, Greece, Spain, Italy III, France, Germany, Finland, United Kingdom, Belgium, Sweden, Denmark IV, Austria, Iceland, The Netherlands, Switzerland, Ireland, Norway, Luxembourg Sources: United Nations Population Division. For GDP International Monetary Fund

  5. LIFE EXPECTANCY TRENDS IN EUROPE Inequalities in health increased Source: United Nations Population Division

  6. INFORMATION IS THE KEY • We know LE because population level current statistics are made available • LE in Europe are improving as disparities do • Wealth appears related to these phenomena AND CANCER ?….

  7. GROSS DOMESTIC PRODUCT (GDP) AND CANCER INCIDENCE Age-standardized incidence rates, World Standard Population per 100,000, GDP: at current prices US $, 2006. Source: GLOBOCAN 2002, IARC & United Nations (UN)

  8. GROSS DOMESTIC PRODUCT (GDP) AND CANCER MORTALITY Age-Standardized incidence rates, World Standard Population per 100,000, GDP: at current prices US $, 2006. Source: GLOBOCAN 2002, IARC & United Nations (UN)

  9. GDP and age-standardized mortality rates for all cancers. Men Disks are proportional to the public health expenditure ($ PPP) Sources: Human Development Report 2009; Ferlay et al. 2008

  10. GDP and age-standardized incidence rates for all cancers. Men Sources: Human Development Report 2009; Ferlay et al. 2008

  11. GDP AND EPIDEMIOLOGICAL CANCER DATA All cancers M & F Sources: Ferlay et al. EJC, 2010. EUROCARE-4. For GDP International Monetary Fund

  12. Age standardised -prevalence (P), -incidence (I), and -survival, all cancers combined, m + w, 1992 The area of the disk is proportional to the 5-year relative survival TREATMENT ACTS TO INCREASE PREVALENCE Source: Micheli et al Annals of Oncology, 2002 PREVENTION AIMS TO REDUCE INCIDENCE

  13. Number of new cancer cases per year Number of cancer publications per year Scientific contributions in cancer domain and cancer burden in 2002 English language "the 15 most wealthy countries are ordered by decreasing gross domestic product level"

  14. EUROCARE-45-year relative survival, all cancerscountries are orded by Total Expenditure on Healh Europe Berrino F. et al, The Lancet Oncology, 2007

  15. 5 YEARS RELATIVE SURVIVAL FOR ALL CANCERS Ranked by 1995 TNEH Source: Verdecchia A. et al. European Journal of Public Health, 2008

  16. EUROCHIP-1 2002-04EUROCHIP-2 2005-07EUROCHIP-3 2008-11 • development of a list of cancer health indicators • using indicators to promote actions for cancer control • promoting common view of cancer plan: collaborative actions • By consensus conferences involving cancer experts of EU institutes, organisations and cancer networks

  17. EUROCHIP INDICATORS 1. Outcome Stage at diagnosisIncidenceSurvivalPrevalenceMortality & PYLL 2. Health determinants Prevention Socio-economic indicators Tobacco Alcohol Fruit and vegetables Sun radiation Occupationalcarcinogens BMI & Physical activity GDP Total Health expenditure Public health expenditure Anti-tobacco regulations 3. Health system indicators Screening Care & Treatment Organised screening coverage % with mammography % with cervical cytologyexam % with colorectal cancer screening test Radiation equipments CTS Palliative radiotherapy Delay of cancer treatment Compliance with guidelines

  18. The burden of Cancer in Europe • According estimates for 2006, there were about 2.3 million new cases of cancer and over 1 million cancer deaths in the EU25 (Cancers of the breast (in women), prostate, colorectum (colon and rectum combined, or large bowel) and lung accounted for over half the total cancer incidence burden • Female breast cancer (320,000 new cases) was the most frequent cancer, closely followed by both prostate and colorectal cancer (300,000 new cases) • Lung cancer ranked fourth, with an estimated 265,000 new cases Source: Responding to the challenge of cancer in Europ,Fealy et al,2007.

  19. EU AGAINST CANCER IMPROVE INFORMATION Activate, expand, improve cancer registration

  20. Health Strategies in Europe. Lisbon, 12-13 July 2006. Coleman M. Health Strategies in Europe. Lisbon, 12-13 July 2006. Coleman M.

  21. CANCER REGISTRY: RECOMMENDATIONS • Cancer Registries should inform the evaluation of programmes for: prevention (incidence), screening, treatment (survival). And, on long term follow-up for cure, care, social support, rehabilitation plans • Update the EU Directive (1995) to enable population-based registries • EU should recommend that all MS make cancer registration statutory, with special coverage by low in collecting data to avoid conflicts with the rights of confidentiality • Set EU standards for registration in countries with no cancer registry. Greece and Luxembourg and .. Health Strategies in Europe. Lisbon, 12-13 July 2006. Coleman M.

  22. Cancer is an element of our societies • To reduce risks: smoking&alcohol habits, bad diet, • insufficient physical activity, remove carcinogens • To improve the cure, • To support those who experienced the disease • To promote actions for cancer control • Cancer registry population based information • is the key

More Related